Precigen, Inc.

NASDAQ:PGEN

Biotechnology

Healthcare
$4.16 -2.08%

-$0.10 today

Market cap
$1.49B
Beta
1.06
P/E (TTM)
-7.1
EPS (TTM)
-$0.65
52W Low $1.39High $5.47

Volume 4.37M

Average 4.72M

Income Statement

Follow revenue through to earnings.

Revenue

$9.68M

FY 2025 · Annual

+146.7% YoY

Operating Income

-$106.60M

FY 2025 · Annual

Net Income

-$250.64M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue14.27M26.91M6.23M3.93M9.68M
Cost of Revenue53.68M6.34M6.12M4.27M6.1M
Gross Profit(39.41M)20.57M106K(342K)3.59M
Gross Margin-276.2%76.4%1.7%-8.7%37.1%
Research & Development47.93M47.17M48.61M53.07M40.06M
Selling, General & Admin048.01M40.42M41.29M70.13M
Operating Expenses52.54M96.3M99.86M134.69M110.19M
Depreciation & Amortization13.76M10.77M6.67M4.53M3.2M
EBITDA(77.64M)(62.43M)(89.23M)(123.5M)(243.57M)
EBITDA Margin-544.2%-232.0%-1433.3%-3146.4%-2515.2%
Operating Income(91.95M)(75.73M)(99.76M)(135.03M)(106.6M)
Operating Margin-644.5%-281.4%-1602.5%-3440.2%-1100.8%
Interest Income171K133K3.24M1.42M3.22M
Interest Expense18.76M6.77M468K6K3.87M
Other Income / Expenses(19.02M)(4.24M)3.4M7M(144.04M)
Income Before Tax(110.97M)(79.97M)(96.36M)(128.03M)(250.64M)
Pre-Tax Margin-777.8%-297.2%-1548.0%-3261.9%-2588.2%
Income Tax Expense(160K)(189K)(458K)(1.79M)3K
Net Income(92.17M)28.32M(95.9M)(126.24M)(250.64M)
Net Margin-646.0%105.2%-1540.6%-3216.2%-2588.2%
EPS (Basic)(0.47)(0.33)(0.39)(0.47)(1.41)
EPS (Diluted)(0.47)(0.40)(0.39)(0.47)(1.41)
Weighted Avg Shares197.76M200.36M244.54M267.73M304.71M
Weighted Avg Shares (Diluted)197.76M200.36M244.54M267.73M304.71M

PGEN Earnings Waterfall · TTM

NASDAQ:PGEN · Revenue to Net Income

Key Ratios

EPS$-1.14
Gross Margin73.6%
Net Margin-1380.2%
P/E Ratio-7.7
P/S Ratio177.4

Analysis

$85.7M of revenue converted into -$157.7M of net income for the selected period. Gross margin is 73.6% and net margin is -1380.2%, showing how much revenue survives after costs and taxes. EPS is $-1.14, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 5, 2026
10-QQuarterly reportNov 4, 2026
4Statement of changes in beneficial ownershipSep 24, 2026
4Statement of changes in beneficial ownershipAug 28, 2026
4Statement of changes in beneficial ownershipAug 25, 2026

How much revenue does PGEN generate?

Precigen, Inc. (PGEN) reported $9.68M of revenue in fiscal 2025.

Is PGEN profitable?

Precigen, Inc. (PGEN) reported -$250.64M of net income, with a net margin of -2588.2%.